302 related articles for article (PubMed ID: 27617576)
1. Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.
Fang D; Chen H; Zhu JY; Wang W; Teng Y; Ding HF; Jing Q; Su SB; Huang S
Oncogene; 2017 Mar; 36(11):1546-1558. PubMed ID: 27617576
[TBL] [Abstract][Full Text] [Related]
2. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
3. IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer.
Bley N; Schott A; Müller S; Misiak D; Lederer M; Fuchs T; Aßmann C; Glaß M; Ihling C; Sinz A; Pazaitis N; Wickenhauser C; Vetter M; Ungurs O; Strauss HG; Thomssen C; Hüttelmaier S
RNA Biol; 2021 Mar; 18(3):391-403. PubMed ID: 32876513
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation.
Hoang VT; Matossian MD; La J; Hoang K; Ucar DA; Elliott S; Burks HE; Wright TD; Patel S; Bhatt A; Phamduy T; Chrisey D; Buechlein A; Rusch DB; Nephew KP; Anbalagan M; Rowan B; Cavanaugh JE; Flaherty PT; Miele L; Collins-Burow BM; Burow ME
J Cell Biochem; 2021 Aug; 122(8):835-850. PubMed ID: 33876843
[TBL] [Abstract][Full Text] [Related]
5. Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.
Franke FC; Slusarenko BO; Engleitner T; Johannes W; Laschinger M; Rad R; Nitsche U; Janssen KP
Int J Cancer; 2020 Sep; 147(6):1715-1731. PubMed ID: 32147820
[TBL] [Abstract][Full Text] [Related]
6. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory short peptides targeting EPS8/ABI1/SOS1 tri-complex suppress invasion and metastasis of ovarian cancer cells.
Yu X; Liang C; Zhang Y; Zhang W; Chen H
BMC Cancer; 2019 Sep; 19(1):878. PubMed ID: 31488087
[TBL] [Abstract][Full Text] [Related]
8. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
9. Pro-migratory and TGF-β-activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch.
Tod J; Hanley CJ; Morgan MR; Rucka M; Mellows T; Lopez MA; Kiely P; Moutasim KA; Frampton SJ; Sabnis D; Fine DR; Johnson C; Marshall JF; Scita G; Jenei V; Thomas GJ
J Pathol; 2017 Sep; 243(1):37-50. PubMed ID: 28608476
[TBL] [Abstract][Full Text] [Related]
10. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
11. Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.
Das S; Becker BN; Hoffmann FM; Mertz JE
BMC Cell Biol; 2009 Dec; 10():94. PubMed ID: 20025777
[TBL] [Abstract][Full Text] [Related]
12. Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis.
Chen H; Wu X; Pan ZK; Huang S
Cancer Res; 2010 Dec; 70(23):9979-90. PubMed ID: 21118970
[TBL] [Abstract][Full Text] [Related]
13. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
Leng R; Liao G; Wang H; Kuang J; Tang L
Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
[TBL] [Abstract][Full Text] [Related]
14. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
[TBL] [Abstract][Full Text] [Related]
15. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
[TBL] [Abstract][Full Text] [Related]
16. Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition.
Ouelaa-Benslama R; De Wever O; Hendrix A; Sabbah M; Lambein K; Land D; Prévost G; Bracke M; Hung MC; Larsen AK; Emami S; Gespach C
Int J Oncol; 2012 Jul; 41(1):189-200. PubMed ID: 22552300
[TBL] [Abstract][Full Text] [Related]
17. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
18. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
19. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
Xu M; Zhu C; Zhao X; Chen C; Zhang H; Yuan H; Deng R; Dou J; Wang Y; Huang J; Chen Q; Jiang B; Yu J
Oncotarget; 2015 Jan; 6(2):979-94. PubMed ID: 25460509
[TBL] [Abstract][Full Text] [Related]
20. Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis.
Lemieux E; Bergeron S; Durand V; Asselin C; Saucier C; Rivard N
Int J Cancer; 2009 Oct; 125(7):1575-86. PubMed ID: 19462441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
